==== Front Ann Indian Acad NeurolAnn Indian Acad NeurolAIANAnnals of Indian Academy of Neurology0972-23271998-3549Medknow Publications & Media Pvt Ltd India AIAN-21-9510.4103/aian.AIAN_296_18EditorialMultiple Sclerosis in India Goyal Vinay Department of Neurology, All India Institute of Medical Sciences, New Delhi, IndiaAddress for correspondence: Dr. Vinay Goyal, Room No 706, Department of Neurology, All India Institute of Medical Sciences, New Delhi - 110 029, India. E-mail: drvinaygoyal@gmail.comApr-Jun 2018 21 2 95 97 Copyright: © 2006 - 2018 Annals of Indian Academy of Neurology2018This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. ==== Body This issue of AIAN has many articles on multiple sclerosis (MS), so I thought of reviewing article published on MS from India. Older belief that MS is rare in India to present setting of suspecting MS in every correct case scenario has been shown by increasing number of publications from India. This article has tried to review publication on MS from Indian authors. Since the first publication of 6 cases by Singh and Gupta,[1]there has been increasing number of publication from India, due to improving diagnostic facility including pathologically cases by Dastur and Singhal.[2] Singhal and Wadia, described 30 cases of MS and neuromyelitis optica (NMO), observed over 15 years breaking the myth that MS is uncommon in India.[3]Chopra et al. reported 54 patients with MS from Northwest India with 2 pathologically proven cases and 5 cases with Devic's disease.[4]This study reported more common occurrence of optic neuritis (ON), myelopathy, and higher incidence of classical neuromyelitis optica (NMO). Wadia and Bhatia reported MS in Parsi population with a crude prevalence ratio of 26–58/100,000 from Mumbai/Pune=(age-adjusted prevalence ratio for Mumbai was 24/100,000, with 95% confidence limits of 13.1–40.3, which is same as the rest of the world.[56]Trikannad et al.[7]reported HLA-B12 in Parsi and non-Parsi Indians. Chand and Devi showed the utility of blink reflex and somatosensory-evoked potential in predicting conversion of ON to clinically suspect MS.[8]Jain and Maheshwari complied data of largest case series of 354 cases of MS published from India over the previous three decades and again confirmed higher incidence of ON and NMO.[9]The study also reported that MS might be more common in northern part of India as compared to south based on this data. Singhal[10]reported approximate prevalence rate of 0.17–1.33/100,000 of population in different parts of India based on hospital data record (105 cases of clinical data management systems [CDMS] and 14 cases of NMO from Mumbai region, 1957–1983). The study reported that MS in India is more like other Asian countries as compared to the West with higher incidence of NMO (6%). Common MS was opticospinal form of MS (71.4%) but lesser of cerebellar involvement in the higher socioeconomic group. Bansil et al. compared the population of India and USA in a case–control study and concluded that involvement of the cerebral hemispheres, cerebellum, spinal cord and brainstem were same including disease progression while ON was more frequent in Indian patients. There were no familial cases.[11]In another publication, Bansil et al. looked at environmental risk factors in Indian patients and reported no difference in prior foreign travel, surgeries, blood transfusions, clinical chicken pox and mumps infections and exposure to cats/farm animals as risk factors. There was more exposure to clinical measles infection and dog exposure in the MS patients.[12] Singh et al. studied differences in imaging of MS and acute disseminated encephalomyelitis (ADEM). The study included 33 patients with 14 as CDMS and 19 as ADEM.[13]Banerjee et al. first reported pediatric MS.[14]Chopra et al. (2002) evaluated cerebrospinal fluid (CSF) beta-1-globulin in MS and ADEM. It was significantly higher in ADEM (P < 0.05). The negative predictive value (>6.5%) was 100% for diagnosing MS helping in differentiating between MS and ADEM patients. Sahota et al. evaluated the utility of transcranial magnetic stimulation (TMS) as diagnostic utility in MS.[15]The study found TMS to be very useful tool in detecting corticospinal conduction abnormalities in MS that may have no clinical correlate and in monitoring the course of the disease. Narayan et al. reported MS in Keralite migrated to Middle East in two siblings.[16]At this time, familial MS was not reported from India. Pandit wrote about the experience of mitoxantrone (MTX) in MS.[17]Singhal et al. same year reported his experience of MTX in 23 patients with MS/NMO and concluded that benefit persisted 2.5 years after completion of therapy with 15% developing neutropenia and 2 patients cardiotoxicity and required discontinuation of MTX. Gupta et al. reported the first experience of beta-interferon in 16 patients.[18] Santra and Ray reported the first case of Marburg's variant of MS.[19]Dudani et al. studied the relation of Vitamin D and MS and reported that higher Vitamin D level had lower risk of MS.[20]Pandit et al. also had similar observations.[21] Pandit et al. failed to show any relation between Epstein–Barr virus infection with MS in the study of 140 patients with MS.[22]Patil et al. evaluated the effect of yoga on neurogenic bladder in MS and concluded that doing 2 hours of yoga (various practices) for 21 days improved neurogenic bladder.[23]Nagraj et al. in a case–control study evaluated fatigue in patients with MS and concluded that severe fatigue was significantly more in patients with MS as compared to control[24]and it was also found to be associated with depression and sleep disturbance[25]which was also reported later by Chennadurai et al.[26] Saxena et al. evaluated retinal nerve fiber layer (RNFL) thinning in MS and found reduced thickness of RNFL which also correlated to visual symptoms[27]and later his group also reported that ganglion cell layer + ganglion cell-inner plexiform layer thickness is a more sensitive clinical structural marker than RNFL in early MS with/without ON.[28] Jena et al. evaluated the natural study of MS in 157 patients and concluded that there is higher incidence of opticospinal onset, higher cases of relapsing–remitting MS (RRMS) and poor utility of CSF study.[29]Pandit et al. evaluated 109 European-associated variants in a total of 270 patients with MS and 555 controls and showed that two-third of variants overlapped suggesting similarity in etiology irrespective of ethnicity[30]as well as human leukocyte antigen (HLA) (DRB1 × 15:01 and DRB1 × 03 alleles) similarity[31]and also showed CD6 gene polymorphism rs17824933 as seen in European population.[32]Zahoor et al. evaluated Ile587Val polymorphism of the EIF2B5 gene in MS in Kashmir and did not find any polymorphism[33]and also reported the clinical profile of 14 patients of MS from Kashmir.[34] Pandit et al. reported the usefulness of mycophenolate mofetil in 40 patients with MS used for 2 years. Singhal et al. reported clinical details of 105 patients (68.4% RRMS, 16.8% secondary progressive MS, and 14.8% PPMS) with MS from northern tertiary center with mean disease duration of 6 years, mean expanded disability status scale at presentation of 3.2 and found similarity between published data from western countries.[35]Malli et al. evaluated the risk factors for MS (139 MD and 278 control) and concluded with measles (P < 0.007), vegetarian diet (P < 0.001, higher educational status (P < 0.0001) and urban living (P < 0.0001) as risk factors while Helicobacter pylori infection (P < 0.001) was protective.[36]A study by Chinnadurai et al. suggested cognitive fatigue in patients with MS.[37]Chinnadurai et al. interestingly showed that P13, N10, and P37 latencies strongly predicted falls in patients with MS (134 patient with MS).[38] Looking at the published literature on MS from India, suggests that there were no have been no studies with, basic science research work which is of groundbreaking research, path changing, or novel ideas. So this, which must stimulates younger researchers to look into the available literature and plan their research work beyond that rather than repeating same in Indian population or just looking for new mutation in India patients. I presume this article might stimulate few researchers to work toward new fields of research in MS. ==== Refs REFERENCES 1 Singh H Gupta VK Multiple sclerosis (clinical study of sixteen cases) J Assoc Physicians India 1964 12 293 7 14137607 2 Dastur DK Singhal BS Two unusual neuropathologically proven cases of multiple sclerosis from Bombay J Neurol Sci 1973 20 397 414 4772397 3 Singhal BS Wadia NH Profile of multiple sclerosis in the Bombay region. On the basis of critical clinical appraisal J Neurol Sci 1975 26 259 70 1176993 4 Chopra JS Radhakrishnan K Sawhney BB Pal SR Banerjee AK Multiple sclerosis in North-West India Acta Neurol Scand 1980 62 312 21 7468154 5 Wadia NH Bhatia K Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India Ann Neurol 1990 28 177 9 2221846 6 Bharucha NE Bharucha EP Wadia NH Singhal BS Bharucha AE Bhise AV Prevalence of multiple sclerosis in the Parsis of Bombay Neurology 1988 38 727 9 3362370 7 Trikannad VS Wadia NH Krishnaswamy PR Multiple sclerosis and HLA-B12 in Parsi and non-Parsi Indians. A clarification Tissue Antigens 1982 19 155 7 7101268 8 Chand RP Devi MG The blink reflex and somatosensory evoked potential in optic neuritis in South India Acta Neurol Scand 1985 71 150 5 3984682 9 Jain S Maheshwari MC Multiple sclerosis: Indian experience in the last thirty years Neuroepidemiology 1985 4 96 107 3913869 10 Singhal BS Multiple sclerosis – Indian experience Ann Acad Med Singapore 1985 14 32 6 4004124 11 Bansil S Singhal BS Ahuja GK Ladiwala U Behari M Friede R Comparison between multiple sclerosis in India and the United States: A case-control study Neurology 1996 46 385 7 8614499 12 Bansil S Singhal BS Ahuja GK Riise T Ladiwala U Behari M Multiple sclerosis in India: A case-control study of environmental exposures Acta Neurol Scand 1997 95 90 5 9059727 13 Singh S Prabhakar S Korah IP Warade SS Alexander M Acute disseminated encephalomyelitis and multiple sclerosis: Magnetic resonance imaging differentiation Australas Radiol 2000 44 404 11 11103538 14 Banerjee TK Mukherjee A Bhargava A Childhood multiple sclerosis – report of two Indian cases J Assoc Physicians India 2002 50 1091 2 12421044 15 Sahota P Prabhakar S Lal V Khurana D Das CP Singh P Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis Neurol India 2005 53 197 201 16010059 16 Narayan SK Kumar S Prabhakar P Elangovan S Baumann N Verma IC Multiple sclerosis in keralite siblings after migration to the middle east: Areport of familial multiple sclerosis from India J Neurol Sci 2007 260 244 8 17588606 17 Pandit L Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: Experience in an Indian tertiary care setting Neurol India 2009 57 424 5 19827224 18 Gupta S Varadarajulu R Ganjoo RK Beta-interferons in multiple sclerosis: A single center experience in India Ann Indian Acad Neurol 2010 13 132 5 20814498 19 Santra G Ray AC Marburg's variant of multiple sclerosis J Assoc Physicians India 2009 57 580 20209719 20 Dudani SJ Kalhan S Sharma SP Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications Int J Appl Basic Med Res 2011 1 71 4 23776780 21 Pandit L Ramagopalan SV Malli C D'Cunha A Kunder R Shetty R Association of Vitamin D and multiple sclerosis in India Mult Scler 2013 19 1592 6 23519972 22 Pandit L Malli C D'Cunha A Shetty R Singhal B Association of Epstein-Barr virus infection with multiple sclerosis in India J Neurol Sci 2013 325 86 9 23312038 23 Patil NJ Nagaratna R Garner C Raghuram NV Crisan R Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis – A prospective observational case series Complement Ther Med 2012 20 424 30 23131373 24 Nagaraj K Taly AB Gupta A Prasad C Christopher R Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life J Neurosci Rural Pract 2013 4 278 82 24250159 25 Nagaraj K Taly AB Gupta A Prasad C Christopher R Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue J Neurosci Rural Pract 2013 4 387 91 24347942 26 Chinnadurai SA Gandhirajan D Pamidimukala V Kesavamurthy B Venkatesan SA Analysing the relationship between polysomnographic measures of sleep with measures of physical and cognitive fatigue in people with multiple sclerosis Mult Scler Relat Disord 2018 24 32 7 29883851 27 Saxena R Bandyopadhyay G Singh D Singh S Sharma P Menon V Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis Indian J Ophthalmol 2013 61 562 6 24212307 28 Pillay G Ganger A Singh D Bhatia R Sharma P Menon V Retinal nerve fiber layer and ganglion cell layer changes on optical coherence tomography in early multiple sclerosis and optic neuritis cases Indian J Ophthalmol 2018 66 114 9 29283135 29 Jena SS Alexander M Aaron S Mathew V Thomas MM Patil AK Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital Neurol India 2015 63 866 73 26588619 30 Pandit L Ban M Beecham AH McCauley JL Sawcer S D'Cunha A European multiple sclerosis risk variants in the South Asian population Mult Scler 2016 22 1536 40 26754803 31 Pandit L Malli C Singhal B Wason J Malik O Sawcer S HLA associations in South Asian multiple sclerosis Mult Scler 2016 22 19 24 25921049 32 D'Cunha MA Pandit L Malli C CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population Ann Indian Acad Neurol 2016 19 491 4 27994359 33 Zahoor I Asimi R Haq E No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir valley of India J Neurol Sci 2015 359 172 6 26671108 34 Zahoor I Asimi R Haq E Yousuf Wani I Demographic and clinical profile of multiple sclerosis in Kashmir: A short report Mult Scler Relat Disord 2017 13 103 6 28427689 35 Singhal A Bhatia R Srivastava MV Prasad K Singh MB Multiple sclerosis in India: An institutional study Mult Scler Relat Disord 2015 4 250 7 26008942 36 Malli C Pandit L D'Cunha A Mustafa S Environmental factors related to multiple sclerosis in Indian population PLoS One 2015 10 e0124064 25902359 37 Chinnadurai SA Venkatesan SA Shankar G Samivel B Ranganathan LN A study of cognitive fatigue in multiple sclerosis with novel clinical and electrophysiological parameters utilizing the event related potential P300 Mult Scler Relat Disord 2016 10 1 6 27919474 38 Chinnadurai SA Gandhirajan D Srinivasan AV Kesavamurthy B Ranganathan LN Pamidimukkala V Predicting falls in multiple sclerosis: Do electrophysiological measures have a better predictive accuracy compared to clinical measures? Mult Scler Relat Disord 2018 20 199 203 29414299